Free Trial

IBEX Limited (NASDAQ:IBEX) Shares Sold by Royce & Associates LP

IBEX logo with Business Services background

Key Points

  • Royce & Associates LP has reduced its holdings in IBEX Limited by 23.7%, now owning 418,648 shares worth $10.19 million as of the latest SEC filing.
  • Insider selling occurred recently, with CEO Robert Thomas Dechant selling 15,000 shares, resulting in a 7.02% decrease in his position, and other insiders also sold a total of 63,910 shares last quarter.
  • IBEX stock has seen a recent decline, opening at $29.79, with a market capitalization of $398.35 million and a 52-week range between $15.17 and $32.08.
  • Looking to export and analyze IBEX data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Royce & Associates LP lessened its position in shares of IBEX Limited (NASDAQ:IBEX - Free Report) by 23.7% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 418,648 shares of the company's stock after selling 129,833 shares during the period. Royce & Associates LP owned approximately 3.17% of IBEX worth $10,194,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the business. JPMorgan Chase & Co. boosted its position in shares of IBEX by 1,369.6% in the fourth quarter. JPMorgan Chase & Co. now owns 284,292 shares of the company's stock worth $6,109,000 after buying an additional 264,947 shares during the period. Dimensional Fund Advisors LP boosted its position in shares of IBEX by 30.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 326,141 shares of the company's stock worth $7,009,000 after buying an additional 76,302 shares during the period. Walleye Capital LLC boosted its position in shares of IBEX by 267.2% in the fourth quarter. Walleye Capital LLC now owns 102,220 shares of the company's stock worth $2,197,000 after buying an additional 74,380 shares during the period. Two Sigma Advisers LP boosted its holdings in IBEX by 97.7% in the fourth quarter. Two Sigma Advisers LP now owns 145,700 shares of the company's stock valued at $3,131,000 after purchasing an additional 72,000 shares during the last quarter. Finally, Segall Bryant & Hamill LLC purchased a new position in IBEX in the fourth quarter valued at about $1,169,000. Institutional investors and hedge funds own 81.24% of the company's stock.

Insider Activity at IBEX

In other IBEX news, insider Paul Joseph Inson sold 3,690 shares of IBEX stock in a transaction on Tuesday, May 27th. The stock was sold at an average price of $28.59, for a total transaction of $105,497.10. Following the sale, the insider owned 17,352 shares of the company's stock, valued at $496,093.68. The trade was a 17.54% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Robert Thomas Dechant sold 4,376 shares of IBEX stock in a transaction on Thursday, July 3rd. The shares were sold at an average price of $30.00, for a total value of $131,280.00. Following the sale, the chief executive officer directly owned 193,633 shares in the company, valued at $5,808,990. The trade was a 2.21% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 63,910 shares of company stock worth $1,874,647 in the last ninety days. 6.72% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

IBEX has been the topic of a number of research analyst reports. Baird R W downgraded shares of IBEX from a "strong-buy" rating to a "hold" rating in a research note on Monday, May 12th. Robert W. Baird downgraded IBEX from an "outperform" rating to a "neutral" rating and set a $30.00 target price on the stock. in a report on Monday, May 12th.

Read Our Latest Stock Analysis on IBEX

IBEX Stock Performance

Shares of NASDAQ IBEX traded down $0.05 during mid-day trading on Tuesday, hitting $29.98. The company had a trading volume of 17,959 shares, compared to its average volume of 173,046. The stock has a market cap of $400.83 million, a price-to-earnings ratio of 13.08 and a beta of 0.77. IBEX Limited has a 12 month low of $15.17 and a 12 month high of $32.08. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.67 and a quick ratio of 1.67. The firm's 50 day simple moving average is $29.29 and its two-hundred day simple moving average is $26.19.

About IBEX

(Free Report)

IBEX Limited provides end-to-end technology-enabled customer lifecycle experience solutions in the United States and internationally. The company products and services portfolio includes ibex Connect, that offers customer service, technical support, revenue generation, and other revenue generation outsourced back-office services through the CX model, which integrates voice, email, chat, SMS, social media, and other communication applications; ibex Digital, a customer acquisition solution that comprises digital marketing, e-commerce technology, and platform solutions; and ibex CX, a customer experience solution, which provides a suite of proprietary software tools to measure, monitor, and manage its clients' customer experience.

Further Reading

Institutional Ownership by Quarter for IBEX (NASDAQ:IBEX)

Should You Invest $1,000 in IBEX Right Now?

Before you consider IBEX, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IBEX wasn't on the list.

While IBEX currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Market’s Next Big Winners? Start Here
5 High Short Interest Stocks to Buy Before November
HUGE Upside Ahead: The Fastest Growing ETFs in the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines